Drug recall D-1246-2014
Product
Nicorette (nicotine polacrilex) Lozenges Mini, 4 mg, Original Flavor, 20 Lozenge and 81 Lozenge Vials, OTC. Distributed by GlaxoSmithKline Consumer Healthcare, LP, Moon Township, PA 15108, Made in Switzerland. 20 Count NDC: 0135-0509-04, 81 Count NDC: 0135-0509-02.
Reason for recall
Failed Lozenge Specifications; Lozenges are overly thick, overly soft, and sub and superpotent.
Lots and codes
(20 ct) Lot #14337 (exp 7/15), 14398 (exp 9/15) & 14510 (exp 9/15); (81 ct) Lot #14336 (exp 7/15), 14347 (exp 7/15), 14378 (9/15), 14563 (exp 9/15)
Recall details
- Recalling firm
- GlaxoSmithKline Consumer Healthcare; dba-GlaxoSmithKline, Aiken, SC
- Quantity
- 189,900 20 ct Vials, 145,068 81 ct Vials
- Distribution
- U.S. Nationwide
- Type
- Voluntary: Firm initiated
- Recall initiated
- February 20, 2014
- Terminated
- January 20, 2017
Related products
- Nicorette – drug information
- NDC 0135-0508 Nicorette · Nicotine 2 mg/1 · Haleon US Holdings LLC